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Background: Galectins, a family of non-classically secreted, β-galactoside binding
proteins is involved in several brain disorders; however, no systematic knowledge on the
normal neuroanatomical distribution and functions of galectins exits. Hence, the major
purpose of this study was to understand spatial distribution and predict functions of
galectins in brain and also compare the degree of conservation vs. divergence between
mouse and human species. The latter objective was required to determine the relevance
and appropriateness of studying galectins in mouse brain which may ultimately enable
us to extrapolate the findings to human brain physiology and pathologies.
Results: In order to fill this crucial gap in our understanding of brain galectins, we
analyzed the in situ hybridization and microarray data of adult mouse and human
brain respectively, from the Allen Brain Atlas, to resolve each galectin-subtype’s spatial
distribution across brain distinct cytoarchitecture. Next, transcription factors (TFs)
that may regulate galectins were identified using TRANSFAC software and the list
obtained was further curated to sort TFs on their confirmed transcript expression
in the adult brain. Galectin-TF cluster analysis, gene-ontology annotations and co-
expression networks were then extrapolated to predict distinct functional relevance
of each galectin in the neuronal processes. Data shows that galectins have highly
heterogeneous expression within and across brain sub-structures and are predicted
to be the crucial targets of brain enriched TFs. Lgals9 had maximal spatial distribution
across mouse brain with inferred predominant roles in neurogenesis while LGALS1 was
ubiquitously expressed in human. Limbic region associated with learning, memory and
emotions and substantia nigra associated with motor movements showed strikingly high
expression of LGALS1 and LGALS8 in human vs. mouse brain. The overall expression
profile of galectin-8 was most preserved across both these species, however, galectin-9
showed maximal preservation only in the cerebral cortex.
Conclusion: It is for the first time that a comprehensive description of galectins’ mRNA
expression profile in brain is presented. Results suggests that spatial transcriptome
changes in galectins may contribute to differential brain functions and evolution
across species that highlights galectins as novel signatures of brain heterogeneity and
functions, which if disturbed, can promote several brain disorders.
Keywords: galectin, transcriptomics, neurogenesis, neural stem cell (NSC), brain heterogeneity, molecular
neuroanatomy, Allen Brain Atlas, TRANSFAC
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INTRODUCTION
Galectins is a unique family of non-classically secreted,
β-galactoside binding proteins that has recently received
considerable attention in the spatio-temporal regulation of signal
lattices, membrane trafficking and in the emergence of several
pathologies (Nabi et al., 2015).
Galectins specifically bind to lipids and proteins with a
β-galactoside containing headgroup, although with differential
affinity and avidity, hence are capable of clustering and
organizing dynamic signal lattices on the cell surface through
their carbohydrate recognition domains (CRD; Nabi et al., 2015).
To date, 16 mammalian galectin protein members have been
identified and all of them lack a recognizable signal sequence
for their transport into the classical ER-Golgi cargo trafficking
machinery, hence they are proposed to be secreted out into
the extracellular environment directly from the cytoplasm. All
mammalian galectins have an evolutionary conserved CRD of
about 130 amino acids which binds to oligosaccharides via
recognition of the β-galactoside units (Nabi et al., 2015).
The reported galectins can be further classified into three types
on the basis of number of CRDs as proto, chimera and tandem-
repeat types. Prototype (gal-1, -2,-5, -7, -10, -11, -13, -14, -15, and
-16) are characterized by one CRD, while the chimera-type Gal-3
has one C-terminal CRD and a long N-terminal tail composed
mostly of collagen-like repeats that terminate in a short non-
collagenous terminal peptide sequence. The tandem-repeat type
galectins (gal-4,-6,-8,-9,-12) possesses two CRDs connected by a
linker domain of variable lengths that governs several biophysical
properties and functions of these proteins (Heusschen et al., 2013;
John and Mishra, 2016).
Galectins are known to localize in the extracellular matrix,
nucleus, cytoplasm and in the subcellular organelles wherein
they are reported to have multifarious roles, however, the surface
interactions are predominantly carbohydrate mediated (Dumic
et al., 2006). In the recent years, crucial roles of galectins have
been examined in organogenesis, cell cycle, apoptosis, migration,
adhesion, polarity generation, ciliogenesis, mechanosensing,
surface to nuclear signal transport, RNA splicing, adipogenesis
and immune system functions (Liu, 2005; Dumic et al., 2006;
Baptiste et al., 2007; Sato et al., 2009; Mishra et al., 2010; Rhodes
et al., 2013; Nabi et al., 2015).
Both age and diet are known to crucially influence galectins’
expression across different organs (Rhodes et al., 2013). Hence,
these oligomeric multifunctional proteins are now emerging as
strong regulators of processes ranging from cellular metabolism
to complex disease dynamics and carry the potential to emerge as
novel nanobiotools and biomarkers for disease therapeutics (Nabi
et al., 2015; John and Mishra, 2016).
The first mammalian galectin (RL14.5 or galectin-1) was
initially identified in the process of axon pathfinding amongst
Abbreviation: ABA, Allen Brain Atlas; ABHA, Allen Brain Human Atlas;
BGEM, brain gene expression map; CNS, central nervous system; ISH, in
situ hybridization; symbol ‘lgals’ for mouse galectins; symbol ‘LGALS’ for
human galectins; TF, transcription factor; TOM, topological overlap measure;
TRANSFAC, TRANScription FACtor Database; WGCNA, weighted gene co-
expression network analysis.
some other crucial processes (Hynes et al., 1990) and even
though galectins’ roles are now being established in several
brain disorders such as in neuroblastoma and glioblastomas (Le
Mercier et al., 2010; Veschi et al., 2014), dengue fever (Chagan-
Yasutan et al., 2013; Toledo et al., 2014), ischemia (Walther
et al., 2000; Doverhag et al., 2010; Chen et al., 2014), autism
(Voineagu et al., 2011), multiple sclerosis (Stancic et al., 2011),
experimental allergic encephalomyelitis (EAE) (Reichert and
Rotshenker, 1999) etc., ironically, ‘no systematic studies’ have
been performed on its expression, regulation and functions in
brain’s normal physiology. This missing gap in our knowledge on
brain galectins, could have otherwise established an experimental
framework and a precise map for further dissection of the
complexity of the mammalian brain and mechanisms of its
pathogenesis via an understanding of the normal vs. abnormal
transcription levels.
Since galectins are secreted proteins, their precise spatial
localization in terms of expression (producer cells) can be best
understood by profiling their mRNA transcriptome. In this
context, it is important to determine the distribution of galectin
transcripts ‘at all possible levels of expression’ in both single cells
and in a population of cells across different regions of the brain,
as ‘low level’ transcripts can also act as essential signatures for
determining normal and pathological phenotypes.
Since, transcription factors (TFs) play key roles in the tight
regulation of gene expression, an understanding of those TFs
that regulate various galectins and whose functions in some brain
processes are already defined, can enable us to seek ‘first insights’
into the various functions of galectins in brain physiology and
their associated pathologies.
To this end, as described in workflow (Figure 1), the
Allen Brain Atlas, provided the raw transcript data on galectins’
expression in young adult mouse brain and the microarray
data of human brain, while the TRANSFAC software enabled
the identification of putative TFs that can regulate galectins.
Hence, we extracted, normalized and quantified the galectin
gene expression data and clustered it via separate algorithms
for mouse and human to identify the linkages among galectins
and also with their regulatory TFs in different regions of brain.
Given the fact that ‘weakly expressing’ transcripts are crucial
in brain’s highly tuneable plasticity, our proposed method of
quantitation of expression was necessary as it picked up even the
sparser areas with low intensity expression which were hidden
or not clearly visible in the expression mask provided by the
Allen Institute (please see Supplementary Figure S15). It is to
be noted that Allen Brain Atlas developers encourage such ‘end
user’ data curation as their expression masks are created on
the general methodology of ‘one size fits all’ basis and may
not be highly useful for every research question (Jones et al.,
2009).
Our analysis identified low to moderate expression of
various galectins in the neurons of the olfactory bulb, cortex,
hippocampus, basal ganglia, thalamus, hypothalamus, amygdala,
substantia nigra and the cerebellar cortex. Besides, the brain
regions associated with adult neurogenesis-the olfactory bulb,
rostral migratory stream (RMS), lateral ventricles, subventricular
zone (SVZ), sub-granular zone and the dentate gyrus (DG)
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FIGURE 1 | Flowchart of the experimental strategy: The summary of the experimental logic followed for (i) mRNA expression profiling of galectins in
mouse and human brain, (ii) validation of galectins expression and (iii) prediction of probable functions of galectins in brain via GO analysis based
mining of the known functions of the putative regulatory transcription factors.
showed heterogeneous galectin expressions. All galectins also
had a highly heterogeneous expression within and across
brain sub-structures and were identified (through informatics
prediction) to be the regulatory targets of crucial brain enriched
TFs that have been previously reported for their distinct
roles in brain activities such as proliferation, differentiation,
synaptic transmissions and neuronal survival. Hence, informatics
driven Galectin-TF cluster analysis, gene ontology (GO)
annotations and data driven co-expression networks enabled
prediction of functional relevance of galectins in the neuronal
processes.
The detailed microarray-based analysis of human
transcriptome of individual galectins revealed some diverse
and several other conserved modules between brain regions
within and among the individual human subjects. However,
significant differential galectin signatures were observed for
putatively homologous brain regions in mouse and human.
For example, while Lgals9 (ENSEMBL gene denotion norms:
‘Lgals’ for mouse and ‘LGALS’ for human) had maximal
spatial distribution across brain in mouse, with predicted
predominant roles in neurogenesis; LGALS1 was ubiquitously
expressed in human. Limbic regions which are associated
with learning, memory and emotions and substantia nigra
(SN) which is associated with motor movements also showed
strikingly high expression of LGALS1 and LGALS8 in human
vs. mouse brain. The overall expression profile was mostly
preserved across both these species for galectin-8, however,
galectin-9 showed maximal preservation only in the cerebral
cortex.
This study, hence, provides a data and informatics driven
resource on galectin family genes in terms of their relation
to neuronal cell diversity and functions within and across
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species. It highlights both species specific and across species
galectin expression patterns that supports their probable roles
in the evolutionary divergence on one end and conservation
of some basic functional modules on the other. This work
further lays a platform for research on galectins’ probable
roles in the brain physiology and pathogenesis, based on the
modulation of their transcriptome dosages by the regulatory
TFs.
MATERIALS AND METHODS
ISH Images of Mouse Brain
The in situ hybridization (ISH) raw high resolution images were
downloaded from the ABA Atlas for each galectin in three
different planes (lateral, para-sagittal and mid-sagittal from ht
tp://mouse.brain-map.org/ (please see Supplementary Table S1
that provides ABA URL’s list for each galectin ISH images used
for analysis). The reference atlas and Nissl’s stained images
synchronous or corresponding to the respective ISH images
were further downloaded. This study has been performed strictly
according to the ABA ‘citation’1 and ‘terms and use’2 policy.
Please note that averaging over at least 2–3 good quality images in
each plane of section was done to generate the expression profile
(Lein et al., 2007).
A good ABA ISH image was defined by (i) anatomic normalcy,
(ii) dissection quality, (iii) section orientation, (iv) signal-to-
noise ratio, (v) focused image, (iv) uniform illumination of
sample during image acquisition, (vii) absence of tissue artifacts
(bubbles, tears, tissue folds and debris) and (viii) uniform white
balance or background correction3 (follow ‘Documentation’
Tab-Supplemental Data-ABA Data Production Processes and
ISH Platform Controls). According to these criteria, galectins’
predicted regulatory TFs-CEBPA, RNF96/TRIM28 and TCF3
failed ISH quality control and this was directly mentioned
on ABA Image display platform. In addition, GLI3, NANOG,
TAL-1, REX1/REXO1 and ZFX image series showed 1) non-
uniform probe hybridization leading to variation/inconsistency
in signal (color) in multiple adjacent sections and/or 2)
inconsistent hybridization due to presence of sectioning artifacts
such as bubbles, debris, tears and folds in tissue in ‘multiple’
sections, hence these TFs were also eliminated from further
analysis (see Supplementary Table S3). In general, wherever
there were occasional tissue artifacts, bubbles or folds, adjacent
images were used as a representation of a good quality
image.
Expression Analysis
The ISH process is not strongly quantitative in the sense of
measuring transcript copy number; hence in order to detect
the extent of regional expression of galectins and their putative
regulatory TFs, an expression signal detection schema was
devised (see Supplementary Figure S16 for detailed explanations
1http://www.alleninstitute.org/legal/citation-policy/
2http://www.alleninstitute.org/legal/terms-use/
3http://mouse.brain-map.org/
with examples). First the high resolution ABA images were
converted to 8 bit format using freely downloadable-64 bit
Fiji image analysis software [it’s just ImageJ] (Schneider et al.,
2012). This 8 bit image format is associated with a signal
intensity gradient (LUT) in grayscale with pixel intensity values
ranging from highest intensity (index position 0, shade: black)
to lowest (index position 255, shade: white). When images
are visualized in this LUT, the signal will be black or in
shades of gray against white background. In order to better
distinguish the differences in pixel intensities corresponding to
gene expression and to visually describe it, the grayscale LUT
with 256 indexed positions was custom converted to pseudocolor
mask to visualize the expression profile for each image. The
pseudocolor or LUT (Look Up Table: calculated values of output
color data as it corresponds to the input RGB color data)
was created by editing the colors at each index position (Fiji:
Image > Type > Color > Edit LUT > Color entry window
option) generating discrete seven-color scale with decreasing
level of expression (from ‘very very high’ to ‘very very low’ till
‘ no signal’: red–dark orange–orange–yellow–green–blue- dark
blue–black). The following RGB values were entered in the ‘Entry
window’ for each color: red (255,0,0); dark orange (255,124,0);
orange (255,190,0); yellow (255,255,0); green (0,255,0); blue
(0,123,255); dark blue (0,0,255) and black (0,0,0); However,
note that the false color LUT does not change the underlying
grayscale pixel value, which is measured for scoring expression
intensity.
A series of decreasing integers from 7 to 0 were then
assigned to the above color codes to generate a calibration
scale and custom pseudocolor LUT, that is (i) ‘very very
high’/very strong expression (color: red, index position: 0–31,
pixel intensity scale= 7), (ii) ‘very high’/strong expression (color:
dark orange, index position: 32–63, pixel intensity scale = 6);
(iii) ‘high’/above moderate expression (color: orange, index
position: 64–95, pixel intensity scale= 5; (iv) ‘medium’/moderate
expression (color: yellow, index position: 96–127, pixel intensity
scale = 4); (v) ‘low’/below moderate expression (color: green,
index position:128–159, pixel intensity scale = 3); (vi) ‘very
low’/weak expression (color: cyan, index position:160–175, pixel
intensity scale = 2); (vii) detectable but ‘very very low’
expression (color: blue, index position:176–191, pixel intensity
scale = 1); (viii) ‘no expression/no signal’ (color: black; index
position:192–255, pixel intensity scale = 0). This pseudocolor
LUT was saved as a Fiji plug-in and all ISH 8 bit converted
images were edited using the same LUT (in LUT Editor) to
visualize differential expression signal for each gene. Note that
equal ‘intensity’ index positions, that is a total of 32 positions,
were assigned for scales from ‘very high’ expression (red, intensity
scale= 7) to ‘low’ (green, intensity scale= 3) in LUT Editor. The
next 32 index positions below ‘low/green’ were equally divided
into 16 positions each to distinguish weak signals into ‘very low’
and ‘very very low’ pixel intensities. Last 64 index positions (from
192 to 255) were assigned for ‘no signal’ as these mainly positions
corresponds to background intensities in 8 bit gray scale format.
In each image, individual structures were annotated
based on the ABA reference atlas ontology and images
were mapped/marked into regions of interest (ROIs, Fiji:
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Analyze/Tools/ROI Manager) according to the reference atlas4.
The pseudocolor image conversion helped in identifying even
the extremely low level intensity segments and regions. It also
enabled visualization of cohorts/clusters of more intensely
expressing pixels in a region of overall low expression. Hence,
the qualitative details of the visual description of galectin
expression were enhanced. The pseudocolor scale also aided in
quantitative description of the expression signal as ‘heat maps’
(Figure 5) (see Supplementary Datasheet S4: Supplementary
Figure S16/PowerPoint document for further details and examples
for pseudocolor LUT generation and use of color LUT for expression
intensity scaling. Also see steps for scaling density and derivation
of expression factor-which is represented in heat-maps).
To determine expression levels, let’s say of Lgals8 in Cortex
Layer 5 (L5) in parasagittal plane, where the ROI shows ‘a’
cells as blue, ‘b’ cells as green and ‘c’ as yellow and ‘d’ cells
in red, mean gray value associated with these pseudocolor
pixels was ascertained from 8 bit binary images using Fiji:
Image/Threshold and Analyze/Set Measurement (click on mean
gray value and max and min gray value to visualize gray value
range)/Measure tool option to measure the mean gray values
around all expressing pixels in the selected region. Let’s say it
was 169.18 (ranges from minimum 0 to maximum 255), then
expression level (L1) according to above mentioned intensity
scale (from 7 to 0) will receive value of 2 (very low). On
performing similar measurements over three images, in one plane
of section, an average Intensity [L, L = L1 + L2 + L3)/3] can
be obtained. Similar exercise can be followed to yield average
intensity in other planes of sagittal sectioning (mid/lateral as the
case maybe).
In addition, ‘density’ which is the distribution of positively
labeled cells or pixels in a given area over the total number of
cells or pixels present in that area was also considered in analysis.
Fiji tools: Image (8 bit)/Adjust/Threshold; Process/Binary/Make
Binary/Watershed/; Analyze/Tools/ROI (assign ROI) were used
followed by Analyze/Measure Particle option for counting
number of positively expressing pixels. ROI selected in Nissl’s
image to mark the Region of Interest (corresponding to relevant
region in the ABA reference atlas) was superimposed on the
ISH image for area normalization. When sum of the areas
of all positive signals (obtained from Fiji) was divided by the
area of the smallest pixel, that is 0.17 µm2 (in Fiji), then
the number of total pixels for the transcript of interest and
total number of pixels available in that area (through Nissl’s
image) were independently obtained. From this, ‘density’ in
percentage was calculated (% density Np, Np = [(sum of areas
of all pixel intensities for a transcript in a ROI/0.17)/(sum
of areas of all pixel intensities for Nissl’s image in the same
ROI/0.17) ∗100]). The calculated density (in percentage) was
further classified on the scale of 1–4: (a) scale of 1: 0–5% (sparse
distribution); (b) scale of 2 = 5–20% (scattered distribution);
(c) scale of 3 = 20–70% (medium distribution) and (d) scale
of 4 = > 70% (high/wide-spread distribution). For example,
4http://atlas.brain-map.org/atlas?atlas=2#atlas=2&structure=10703&resolution=
15.79&x=7488.142596550707&y=3807.8964917164926&zoom=3&plate=
100883770
say in a Lgals8 ISH image, ROI of parasagittal plane Cortex
Layer 5 (CTX-L5) showed 440358.8 positive pixels while Nissl’s
image showed 9219235 positive pixels in the given ROI, then
the area density is 47.76% and receives a density (D1) value of
3 (medium distribution). On performing similar measurements
over three images, in one plane of section, an average Density
[D, D = (D1 + D2 + D3)/3] can be obtained. Please note
that this kind of analysis was done for each plane of sectioning
using multiple magnification levels to accurately quantify the
expression. Also note that for more dense regions, a robust
manual image thresholding was performed using Fiji (see help
files in Fiji).
In this way, the gene expression in each area can be
subjectively scored according to two parameters: (a) the level of
Intensity (L) and (b) the level of Density (D), i.e., the amount of
area covered by each level of intensity. This methodology was
borrowed from the previously published protocols with a slight
modification (Lein et al., 2007; Sunkin and Hohmann, 2007;
Dahlin et al., 2009).
Different intensity level within an area were averaged (2–3
images in a sagittal sectioning plane) and multiplied with the
average of density level within an area to provide an average
expression factor (E) for one specific area or sub-structure in the
mouse brain. This can be further represented by the following
relationship:
E = L × D, (1)
where L is average of different intensities and D is an average of
respective different densities.
Since there are seven intensity levels and four density levels,
the upper limit for average expression factor in individual
subregions was 28 and the lower limit was 0. These expression
factors were further assigned the following categories: ‘very low’
(where, 0 < E < 6), ‘low’ (where, 6 < E < 11), ‘moderate’ (where,
11< E< 17), ‘high’ (where, 17< E< 22) and “very high” (where,
E > 22).
Hence, using the average values of Intensity (L) and Density
(D) functions in the above examples for CTX L5 ROI,
where say intensities (L1, L2, L3) for three images are 2,2,1
and densities (D1, D2, D3) are: 3,3,3 then expression factor
E = [L1xD1 + L2xD2 + L3xD3/3] will be 5. So, in this example,
expression factor for CTX L5 for Lgals8 will be categorized as
overall ‘very low’ (as 0 < E < 6).
Please see Supplementary Table S4 for detailed expression
analysis (heat maps). Note that expression factor of a house
keeping gene GAPDH is shown to highlight the relative
expression of ubiquitous gene in comparison to galectins and
their predicted TFs in various brain subregions).
Please see Supplementary Method file for further details and
references on (i) Prediction of potential TFs regulating galectins
in mouse and human, (ii) Structures studied in mouse brain
(iii) Expression heatmaps, (iv) GO annotation, (v) Microarray
analysis from Human Allen Brain Atlas and (vi) Network
Construction. To access Allen Brain Atlas white pages and
documents, please see URL: http://mouse.brain-map.org/ and
follow ‘Documentation’ section in Tabs.
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RESULTS
Galectin Family Gene Expression
Analysis in Mouse Brain
To begin, the original ISH image data from the ABA
was identified and extracted for galectin-1,2,3,4,7,8,9, and 12
(Supplementary Table S1). The remaining galectin genes were not
detected in the ABA dataset.
Parallel to this process, a run through TRANSFAC software
enabled us to predict TFs that could regulate galectins’
transcription (Supplementary Table S2). Through this analysis,
a total 34 TFs, for all the galectins combined, were identified in
mouse (Supplementary Table S2). Then with the help of literature
survey, GO annotations and UniProt (2012), evidences for the
involvement of these TFs in the nervous system processes were
examined. Out of the 34 predicted TFs, experimental evidences
for only 30 could be established for some involvement in the
nervous system functions (Supplementary Table S3). The ISH
image data for the 30 TFs were searched in the Allen Brain
Atlas (ABA) and out of these TFs, only 24 were found to have
good quality images (Supplementary Table S3). Upon completion
of this data mining exercise, the ABA sagittal section images
for galectins and their putative regulatory TFs were converted
into ‘8 bit indexed images’ for quantitation of expression in
various brain regions and across different planes of brain
sections, i.e., mid, para and lateral (see Materials and Methods,
Figures 2–4; Supplementary Figures S1–S12, Supplementary
Table S4). The intensity of expression was represented by
the pseudocolor LUT converted images with a calibration bar
Figures 2–4) and the expression factor was represented by
the heatmaps (Figures 5A,B, Supplementary Figures S13 and
S14, Supplementary Table S4). Our expression mask or pseudo-
colored images were found to be much in concert with the
protein expression profile of galectins than the one given by
the Allen brain atlas (for an example see Supplementary Figure
S15 which shows a comparison between mask provided by the
Allen brain atlas, mask created by our methodology and our
antibody mediated detection of galectin-12 protein. Please note
that the same plane of section, same age, same gender and
same mouse strain has been used for precise comparisons. Of
note was the observation that the regional protein expression
data of galectin-12 matched well with our customized mask for
transcript expression. This was further confirmed for Lgals1,
-3 and -9 (Figures 6–8). Also note that due to secretory
nature of galectins, protein expression is more widespread in
comparison to respective transcript profiling of the producer
cells).
Regional Expression Profile of Galectins
in Mouse Brain
To understand the expression dynamics of galectins and their
transcriptional program, we chose to study each structure in
mouse brain individually to determine the cellular context of
their expression.
As shown in Figure 5B, to get correlated genes, galectins
and their putative regulatory TFs were further arranged
in clusters after performing the hierarchical clustering. As
many of the galectins were regulated by multiple similar
TFs (Supplementary Table S3), matching the pattern of TFs
with respect to individual galectin expression further helped
us in making a fair assessment regarding their common
functions.
Hence, we first describe the matched expression profile of
galectins and their putative regulatory TF’s observed in different
structures in the adult mouse brain and then discuss the possible
roles of galectins, which were predicted with the help of region
wise expression and GO (Supplementary Table S5).
From the initial observations of all ABA galectin images
(Figures 2–5), Lgals9 showed the highest expression at the whole
brain level and even individually in the major brain structures
as compared to other galectins. The finer expression details are
described as follows:
The Cerebral Cortex
The cerebral cortex is known to co-ordinate the sensory and
motor information. Anatomically, layer 1 (L1), situated below the
meninges, consists of few neuronal cell bodies, layer 2/3 consists
of granule cells and small pyramidal cells, layer 4 consists of
granule cells, layer 5 is enriched in large pyramidal cells and
layer 6 in fusiform cells (Supplementary Figure S4, see reference
atlas). In particular, layer 4 along with layer 2/3 is associated
with experience dependent plasticity. Layer 4 receives inputs
from outside cortex and distributes it to other cortical layers for
further processing, whereas layer 5 neurons are majorly involved
in voluntary motor movements.
Following the layer-wise schema, we find that Lgals9 had
a widespread expression in layers 2–6 (L2–6) of cortex except
in L1 where it showed very low expression probably due to
the sparseness of cells which were majorly only inhibitory
neurons (Figures 2A and 5A; Supplementary Figure S1).
While Lgals9 and Lgals12 showed ‘low’ expression in L2/3;
galectins-1, 2, 3, 4, 7, and 8 showed ‘very low’ expression
in the same region. Lgals9 was the only galectin with below
moderate expression intensity in L4 while rest of the galectins
had low to very low detectable expression intensities. Layer
5 pyramidal cells expressed galectin-1 and 9 followed by
galectins-3, 8, and 12. Lgals1 showed the strongest expression
intensity in L5 among all the layers but this intensity was
probably due to a few cells that expressed this galectin very
strongly. Also, a few Lgals4 positive cells were detected in
L5-6.
In the galectin-TF co-expression analysis, E2F and EP300,
that were predicted to regulate Lgals9 (Supplementary Tables S2
and S4, Supplementary Figure S4) showed a similar pattern of
expression to Lgals9 but with intensities in a different order of
magnitude (Figure 5B). The expression pattern for Lgals8 in L5
matched with that of SMARCA4, MYC, and EZH2, which were
some of the TFs that possibly regulated Lgals8 (Supplementary
Table S2). This observed diversity in the expression levels
of galectins in the cortex could be due to the diversity and
heterogeneity in the distribution of inhibitory interneurons
(Markram et al., 2004) and also may be due to the complexity
of the cortex itself.
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FIGURE 2 | Galectins expression in mouse Cerebral Cortex, Olfactory Bulb, and Basal Ganglia (A) Expression profile of galectins in cortex with individual
cortical layers marked from L1 to L6b. (B) Expression profile of galectins in olfactory bulb (OB), with different cell layers labeled as GL, glomerular layer; IPL, inner
plexiform layer; OPL, outer plexiform layer; MCL, mitral cell layer and GCL, granule cell layer. (C) Expression profile of galectins in basal ganglia (BG).
The Olfactory Bulb (OB)
The OB transmits smell information from the nose to
the brain and also receives information from the amydala,
neocortex, hippocampus, locus coeruleus and substantia nigra
for odorant/chemical awareness. This input circuitry also enables
odorant associated memory formation for future behavioral
responses. Glomerular layer (GL) is the first level of synaptic
processing in OB and the spatial odor maps organized by
chemicals in this layer can be used for perception of odor in
the olfactory cortex via the participation of the outer plexiform
layer (OPL), the mitral cell layer (MCL), the inner plexiform
layer (IPL) and the granule cell layer (GCL) in OB. OB is
also one of the major sites of adult neurogenesis (please see
Supplementary Figure S1 for diagrammatic representation of OB
layers).
We identified the presence of atleast moderate expression
for Lgals9 in the OB (Figures 2B and 5A, Supplementary
Figure S1B, Supplementary Table S4) in comparison of all
other galectins. Lgals9 showed moderate expression intensity
in the GL, the MCL and the GCL due to a few cells that
had strong expression in these layers in comparison to low
expression intensity of cells in the OPL and the IPL. Overall,
Lgals9 also had the highest average expression in the GCL of
OB amongst all the galectins and TFs examined (Supplementary
Figure S5, Figure 5A). The distribution and low intensity
expression of Lgals8 was apparent in the MCL, accessory olfactory
bulb’s granular cell layer (AOB GCL) and the GL. Lgals1
and Lgals2 showed no major expression but still there were
few cells which were positive for both these galectins in OB.
Galectin-3,-4,-7, and 12 showed very weak positivity throughout
OB.
Among all the predicted TFs which could regulate Lgals9
expression; E2F1, EP300, SETDB1, CTCF, POU5F1 were more
or less moderately expressed in the GCL. Lgals8 expression
in MCL also corroborated well with the positive transcript
signal for many putative TFs regulating its expression, for
example, SMARCA4, SOX2, MYC, FOXP3, KLF4, and CTCF
(Supplementary Figure S5; Figure 5B). For other galectins, no
interesting galectin-TF co-expression was identified.
The Basal Ganglia
The basal ganglion is associated with the control of the voluntary
movements, procedural learning, routine behavior, cognition and
emotions.
The basal ganglion comprises of striatum and palladium and
most of the cells in striatum are GABAergic. Circuits of basal
ganglia that have been shown to be responsible for motor control
include excitatory inputs from the cortex, especially from L2/3
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and L5, intralaminar nuclei of the thalamus and also from the SN
pars compacta toward the striatum. Through the direct pathway,
striatum output projects to globus pallidus interna and SNr, while
via the indirect pathway, they project to globus pallidus externa,
which are the two parallel cortex-basal ganglia-thalamus-cortex
circuits (Kreitzer and Malenka, 2008).
In our study, the striatum and palladium showed comparable
levels of Lgals9 (Figures 2C and 5A). A similar pattern was also
observed for Lgals9 putative regulatory TF E2F1 and to a certain
extent for EP300 (Supplementary Figure S6, Figure 5B). Lgals8
and Lgals12 also showed enough number of cells with average
expression intensity.
The Hippocampus
Hippocampus is made up of the DG and the Ammon’s horn
(or Cornu Ammonis- CA and is subdivided into CA1, CA2, and
CA3). DG is a major site of adult neurogenesis and hippocampus
is known to play major roles in consolidation of short and long
term memories as well as spatial navigation.
Lgals9 showed a ‘wave like expression’ pattern in the
hippocampal subregions with moderate expression in CA1, a
decrease in expression in CA2 and with a slight increase in
CA3 (Figure 3A, Supplementary Figure S2A) The DG pyramidal
neurons were prominently labeled with Lgals9 in some cells near
the base of the granular cell layer (GCL) in sub granular zone
(SGZ), a region defined by the presence of more committed
neural stem/progenitor cells. DG overall showed the strongest
galectin expression across all the hippocampal subregions with
Lgals9 dominating the galectins. For all other galectins, although
the intensity levels in DG were weak, there were few pyramidal
neurons which had below moderate expression in SGZ. Similarly,
a few cells with moderate expression level were identified in
the polymorph layer of DG for galectins-1, 8, 9, and 12. The
molecular layer of DG had weak intensity expression for Lgals9
which was far weaker for all other galectins. Pyramidal layer
(sp) of CA2 showed below moderate expression intensity for
Lgals9 and Lgals12 which was followed by CA1 sp layer’s
with approximately moderate expression for the same galectins,
FIGURE 3 | Galectins expression in mouse Hippocampus, Sub-Ventricular Zone, Thalamus, Hypothalamus and Amygdala (A) Expression profile of
galectins in hippocampus. CA1, Cornu Ammonis1; CA2, Cornu Ammonis2; CA3, Cornu Ammonis3; DG, dentate gyrus; SGZ, sub granular zone. (B) Expression
profile of galectins in lateral ventricle (LV). SVZ, sub ventricular zone; ChP, choroid plexus. (C) Expression profile of galectin in thalamus. (D) Expression profile of
galectins in hypothalamus. (E) Expression profile of galectins in amygdala.
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hence a gradient pattern of expression in the CA region of the
hippocampus was delineated. Lgals1 and Lgals8 showed moderate
expression in the CA3 pyramidal layer and upon comparing the
expression levels in the subiculum (SUB), Lgals8 showed the
strongest expression among all the galectins (Figures 3A and 5A).
Amongst the predicted TF’s that could regulate galectins in
brain, E2F1, EP300 and MYC were strongly expressed in the
Ammon’s horn (Supplementary Figure S7, Supplementary Table
S4, Figure 5B) and these TFs formed a cluster of their own with
Lgals9 having a similar expression pattern for CA1, CA2 to CA3
(Figure 5B). The other putative regulatory TFs for Lgals9 that
showed moderate expression were POU5F1, FOXA2, SETDB1,
CTCF and SMARCA4 (Supplementary Figure S7, Supplementary
Table S4, Figure 5B). Although these TFs did not form a cluster
with Lgals9, they did show a good expression level, similar to
Lgals9. Interestingly, expression profile for Lgals9 in the GCL of
SVZ was observed to be similar for its possible regulators, i.e.,
E2F1, EP300, SMARCA4 and SETDB1.
Although a lot of putative TFs that regulate Lgals2 had a
good expression in the hippocampus, its own expression was
found to be very low which suggests that it may be a low level
and cell-type specific transcript (Figures 3A and 5A). Lgals3,
however, had a good cellular positivity but the intensity weakened
as we moved along CA1–CA3 direction. The TFs HIF1A and
RUNX2 were predicted to regulate Lgals3 and were also found
to be co-expressed in the Ammon’s horn in the ISH images
(Supplementary Figure S7). Few cells in CA1 and DG showed
strong intensities for HIF1A while RUNX2 was slightly weakly
expressed throughout the Ammon’s horn. The expression of
RUNX2 in DG, however, matched with that of Lgals3 at the base
(Supplementary Figure S7; Figure 5B). Putative TFs, SOX2 and
FOXP3 both of which may specifically regulate Lgals8, were also
present in the cluster with it, providing solid assumption for their
regulatory effects on Lgals8 (Figure 5B).
The Lateral Ventricle and the
Subventricular Zone
Subventricular zone that lines the lateral ventricles is well
documented to be enriched in the neural stem cells. The choroid
plexus (ChP) which protrudes into the lateral ventricles and
into the fourth ventricle near the cerebellum is responsible for
secreting the cerebrospinal fluid (CSF) (Brown et al., 2004) and
maintains the outer blood brain barrier (Hilhorat et al., 1973).
This system of ChP-CSF is important for the development of
CNS. ChP is an area which provides access to immune cells
into the CNS and it is composed of large number of T cells
(Lun et al., 2015). Previous studies have suggested its role in
inflammation (Schwerk et al., 2015), ischemia (Doverhag et al.,
2010), Alzheimer’s (González Marrero et al., 2015) and Multiple
Sclerosis (Stancic et al., 2011).
Lgals9 showed moderate to high expression in the SVZ and
ChP (Figures 3B and 5A, Supplementary Figure S8). There
was a heterogeneity of galectins in the SVZ with a few cells
expressing strongly for Lgals3 (Comte et al., 2011) and Lgals12.
The wall opposite to SVZ in lateral ventricle was also positive for
expression of galectin-9, -2, -3, and 4.
Moderate to high expression of Lgals9 in ChP suggested
its various roles in ChP associated immune diseases and
indeed Lgals9 function has been widely documented in the
immunological responses (Wiersma et al., 2013). Other galectins
also had positive expression in ChP but it was of low intensity.
However, Lgals1 showed a below moderate expression.
Some of the TFs which may regulate Lgals9 also had
moderate expression levels in SVZ like E2F1, KLF4, and EP300
(Supplementary Figure S8, Figure 5B, Supplementary Table S4)
while some of them had weaker expression intensities like MYC,
SETDB1, POU5F1, FOXA2 and some were present only in few
cohorts of cells that were moderately positive, as was the case
with EZH2. Lgals3 showed an overall weaker expression in SVZ
where its putative regulatory TFs, FOXP3 and POU5F1 had
the same expression but SOX2, KLF4 and SUZ12 had a higher
expression. In this region, a few cells, weakly expressing galectin-
1, - 2, -4, and 7 were also identified with their putative regulatory
TFs, i.e., CTCF, ESRRB, PPARG which had similar pattern of
expression.
Rostral migratory stream that extends from the lateral
ventricle to the OB had high average expression for Lgals9
along with its the positive expression in the SVZ (Figure 3B),
GCL and the GL in the OB, where neuroblasts finally reach
(Figure 2B). This highlights a role for Lgals9 in the process
of neuroblasts migration, probably as a guidance cue, which is
further supported by its reported role in the cell–cell adhesion
which may assist chain migration in RMS, as previously reported
for Lgals3 (Comte et al., 2011). The RMS was weakly positive
for other galectins too. For Lgals3 and Lgals12, there were few
cells with below moderate expression in both SVZ and different
layers of OB, and the RMS also had a similar kind of expression
for them, revealing a possible involvement in tangential neuronal
migration which has been suggested by a previous study on Lgals3
(Comte et al., 2011). Lgals3 has also been shown to promote
neural cell adhesion (Pesheva et al., 1998) and this function might
help in the process of rostral neuronal migration.
The Thalamus (THA) and the
Hypothalamus (HYP)
Thalamus relays sensory and motor signals to the cerebral
cortex and is involved in regulation of sleep, alertness and
consciousness. Hypothalamus links the nervous system to the
endocrine system via the pituitary gland and is involved in
regulation of body temperature, hunger, thirst, fatigue, sleep,
circadian rhythm and the attachment behaviors.
In both thalamus (THA) and the hypothalamus (HYP), a
high number of cells were positive for Lgals9 and along with
this density there was also an accompanying heterogeneity in
the intensity levels (Figures 3C,D) with cells having low, below
average and average levels of Lgals9 transcript. Thalamic neurons
positive for Lgals8 were few and had low intensity expression.
Lgals12 had about 20% and Lgals1 had around 10% cellular
positivity in the thalamus but with below average intensity. More
than 90% of cells positive for Lgals3 and Lgals7 also showed
low expression levels. The number of Lgals8 positive cells in
the hypothalamus were less but the expressing cells had average
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or above average intensity levels. HYP was also positive for
Lgals12 but only few cells showed the expression. Galectin-3
and 4 too had low intensity level cells in the HYP. The lowest
expression in HYP was for Lgals2 with sparse number of cells
being positive for this galectin. Lgals1 showed less expression
in HYP with a very few cells expressing in different intensity
levels.
E2F1 and EP300 (Supplementary Figure S9, Figure 5B) which
may regulate Lgals9 had the same kind of expression pattern for
almost all the sub regions in HYP. This was also the case with the
thalamus. On the other hand, Lgals3 had weaker but widespread
expression intensity in the THA which could be regulated by
FOXA2 and PPARG. Lgals3 expression could also be regulated
by a few other putative TFs like RUNX2, CTCF, ESRRB, KLF4,
MYCN, STAT3 and CDX2 that had a sporadic expression in THA
and might be enough to transcribe Lgals3. Lgals1 and Lgals2
showed scattered expression with weak intensity and putative
TFs regulating these two galectins were among those with spread
out and scarce expression. Also, both these galectins showed an
overlapping expression pattern.
The Amygdala
Amygdala has primary roles in processing of memory, decision
making and emotional reaction. Amygdala is shown to be
responsible for the acquisition and expression of conditioned
fear through glutamatergic spiny projection neurons, GABAergic
interneurons and the GABAergic medium spiny neurons (Tovote
et al., 2015).
Levels of different galectins in the amygdala (Figure 3E) were
similar to those present in the HYP (Figure 3D) with the highest
levels for Lgals9 and Lgals8 followed by reduction in number of
cells for Lgals12. Lgals3 and Lgals7 positive expression was found
in nearly 70% of the cells of this region but cells had low levels
of expression intensity. Lgals1 and Lgals4 showed the same kind
of expression with very few cells having below average expression
intensity only.
The Cerebellum
The cerebellum is majorly involved in the motor control and
has a unique laminar organization consisting of various types of
neurons with granule cells being predominantly glutamatergic
input neurons of the cerebellar circuitry whereas the Purkinje
cells are GABAergic and act as major output neurons of the
cerebellum.
Cerebellar granule cells (GCL) (Figures 4A and 5A,
Supplementary Figure S3, Supplementary Table S4) expressed
Lgals9 nearly exclusively with few cells having moderate level of
expression in all the lobes and a few cells had above moderate
expression intensity mainly in lobes I/II, IX and X. Lgals3
expressed uniformly in the GCL of the cerebellum, however,
with a very low expression. Similarly, Lgals8 showed a very low
expression in GCL but had a few cells with below moderate
intensity levels. Lgals4 and Lgals12 showed transcript positivity
only in the Purkinje cell layer (PCL), while Lgals3 and Lgals8
showed higher expression in PCL as compared to GCL which
is quite easily distinguishable from the Figure 4 that depicts
a sharp boundary of cells. Lgals1 showed very low expression
levels but it was distributed in a good number of cells making
it clear that it was expressed in the PCL. Molecular layer for all
the galectins showed the lowest expression with an exception
of Lgals9 which had some cells with below average intensity
expression. Lgals3 and Lgals8 showed the highest number of
positive cells with low to moderate average expression in the deep
cerebellar nuclei (DCN) of the cerebellum. This expression in
DCN was closely followed by Lgals1 and Lgals9 which had high
intensity expressing cells with some low intensity expressing cells
too making their average expression slightly less. Galectins -2, 4,
7, and 12 had the lowest expression levels in DCN with only few
positive cells.
The distinctive boundary of PCL in Lgals8 and Lgals3
highly correlated with the expression of MYC and ESRRB
(Supplementary Figure S10, Figure 5B, Supplementary Table S4)
which were predicted to regulate both these galectins. SOX2
FIGURE 4 | Galectins expression in mouse Cerebellum and Substantia nigra (A) Expression profile of galectins in cerebellum. DCN, deep cerebellar nuclei;
WM, white matter; ML, molecular layer; GCL, granular cell layer; PCL, Purkinje cell layer. (B) Expression profile of galectins in substantia nigra.
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FIGURE 5 | Heat map of Galectin-TF gene expression in Para-sagittal plane (A) Heat map of galectins in mouse showing the average expression in each
sub-structure arranged by parent structures. Expression factor of GAPDH is shown as a reference. (B) Heat map of galectins with their putative regulatory
transcription factors showing expression correlations after hierarchical clustering at the level of both gene and structure. Symbol ‘LGALS’ is used instead of ‘lgals’
ENSEMBL denotion for mouse galectins only for uniformity of labeling.
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which may regulate Lgals8 had moderate expression in PCL
and lower expression in GCL which made its presence in PCL
more visible too. PPARG which regulated Lgals3, showed a clear
expression in PCL.
A careful examination of Lgals9 also revealed its expression
in PCL which was otherwise not explicitly visible but Lgals9
regulatory TFs positivity in this layer gave the first indication
of the possibility of its presence in the PCL. E2F1, EP300,
SETDB1 and SMARCA4, the putative TFs of Lgals9 also showed
expression in PCL. STAT3, predicted to regulate both Lgals3 and
Lgals9 also showed a characteristic expression in PCL.
Moderate expression of Lgals9 was observed in GCL which
coincided with the expression pattern of E2F1, EP300 and
MYC. Also SMARCA4, SETDB1, POU5F1 and CTCF positive
cells in GCL showed some heterogeneity in the expression
intensities.
The Substantia Nigra
Substantia nigra is predominantly made up of dopaminergic
neurons and is also a major site for motor co-ordination.
The entire SN region (Substantia nigra pars compacta, SNc;
and Substantia nigra pars reticulata; SNr) (Figures 4B and 5A)
was moderately positive for Lgals9 and its putative regulatory
TFs, with the highest expression of E2F1, SMARCA4, SETDB1
and FOXA2 (Supplementary Figure S11, Figure 5B). Similarly,
Lgals8 had a moderate expression in the whole SN region
but the cellular density was less compared to Lgals9. SOX2
and POU5F1 that putatively regulated Lgals8 showed the same
density but different expression intensities. Interestingly, the TF
FOXA2, which in our TRANSFAC analysis was predicted to
regulate galectins-2, -3, -7, -8, and 9 (Supplementary Table S2)
has been previously documented to regulate multiple phases
of midbrain dopaminergic neuron development. The mouse
lacking a copy of FOXA2 shows abnormalities in the motor
behavior (Ferri et al., 2007; Kittappa et al., 2007). Hence,
the involvement of these galectins in motor behavior could
be extrapolated to galectins 8 and 9 which showed moderate
expression in motor control areas, although galectin-2, -3 and -7
positive neurons could also contribute to motor control functions
even though only a few cells were identified to be positive in
SNc.
Validation of Regional Transcript Profile
With Galectin Protein Expression in the
Mouse Brain
The brain galectins transcriptome analysis was further
substantiated with the evidences of near about matching
patterns of major galectin protein expression (-1, -3, and -9)
in different anatomical regions, however, due to the secretory
nature of this protein, the regional pattern of spread was far
wider, with signal detection in the extracellular matrix and on
the cell surfaces (Figures 6–8). It is to be noted that cells that
showed positive transcript can be much lower in protein levels
than ‘the transcript low or transcript null’ neighboring cells due
to high secretion of these proteins into the microenvironment
for prospective autocrine and paracrine effects.
Functional Annotation of Galectins
Upon identification of the heterogeneous expression of various
galectin transcripts across the brain sub-structures, we resorted to
the literature search (data-based) and GO analysis (informatics-
based) to (i) validate our expression data and observations with
at least some similar evidences in literature [Supplementary
Table S3: worksheet 1 and 2] and (ii) to predict newer
functions of prominent galectins via the extrapolation on
the known functions of their putative TFs (Supplementary
Tables S5 and S6).
In this context, a study has shown an increase in the
expression of Lgals1 in facial motor neurons (VII) after nerve
injury (McGraw et al., 2004) which corroborates well with the
evidence of the presence of Lgals1 in region VII in our expression
analysis. Another functional study for Lgals1 suggests its role in
proliferation of neural progenitors in the hippocampus (Kajitani
et al., 2009), which was also evidenced by the presence of few
positive cells in the SGZ layer of the DG in our own studies
(Figure 3; Supplementary Figure S2). The low expression of
Lgals1 in hippocampus, as observed by us, was also supported
by the study in which the authors had found that Lgals1 was
mainly expressed in the interneurons of the hippocampus that
also expressed axonal marker beta tubulin-III (Kajitani et al.,
2014).
In our survey of Lgals1 functional annotations, the term
‘regulation of apoptotic process’ (P = 1.76E-3) was underpinned.
Indeed, one of the study has suggested selective proapoptotic
role of Lgals1 in a subpopulation of GABAergic interneurons
(Bischoff et al., 2012), hence providing evidence for correctness
of our informatics based predictions. The informatics driven
GO term ‘response to wounding’ (P = 1.16E-3), that was
extrapolated to be the function of Lgals1 based on the roles
of its putative regulatory TFs, was supported by the evidence
where Lgals1 induced astrocyte differentiation and helped in
preventing neuronal loss after injury (Sasaki et al., 2004;
Ishibashi et al., 2007). Some of the TFs (Supplementary Table
S2), such as CTCF (neural development), E2F1 (neurogenesis,
forebrain development), PPARG (neuronal cell survival) and
ESRRB/POU5F1 (stem cell maintenance, cell proliferation) were
predicted to be the regulators of Lgals1, which further supports
the validity of informatics based extrapolations as Lgals1 is
known to play a role in stem cell maintenance and neurogenesis
(Cooper-Kuhn et al., 2002; Wada et al., 2006; Chin et al.,
2009; Watson et al., 2014) (please see Supplementary Table S3:
worksheet 1 and 2). Similarly, through the extrapolations on
the known functions of Lgals1 putative TFs like E2F1 (Wang
et al., 2007), KLF4 (Su et al., 2014), MYCN (Wartiovaara
et al., 2002) and PPARG (Fuenzalida et al., 2007), its role
in neuroprotection was underpinned (Supplementary Table S3:
worksheet 1 and 2).
A recently published study (Sirko et al., 2015) suggested a
regulatory role for galectins 1 and 3 in proliferation and in
imparting neural stem cell potential to a subset of reactive
astrocytes, which supports Lgals3 role in neurogenesis. This
role of Lgals3 was again corroborated with the putative
TFs regulating its expression, which too had some role in
neurogenesis in hippocampus (HIFIA, RUNX2), SVZ (SOX2,
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FIGURE 6 | Comparison and validation of galectins’ mRNA expression with protein profiling in mouse Cerebral cortex and Thalamus. (B,D) ABA based
mRNA expression profile of 3 major galectins in cortex and thalamus was compared with immunohistochemistry based protein expression in the respective regions
as shown in (A,C). The individual cortical layer are marked from L1 to L6b and pseudo-color calibration bar is included to represent the intensity of expression. Note
a good regional corroboration between mRNA and protein expression except that the protein expression is more widespread due to the secretory nature. The
protein is also detected in the extracellular space which is suggestive of autocrine-paracrine effects.
SUZ12, POU5F1), thalamus and the cerebellum (ESRRB,
MYC) (Supplementary Table S3). Possible regulation of Lgals3
by KLF4 in sub-ventricular zone and thalamus predicts its
role in neuronal migration and its possible regulation by
PPARG in thalamus and cerebellum shows an anti-apoptotic
role (Supplementary Table S3). Besides, putative regulation
of Lgals3 by SMARCA4, STAT3 (Matsumoto et al., 2006;
Muller et al., 2009) along with FOXA2 and E2F1 has
already been discussed (Supplementary Tables S3 and S4).
GO classification which was based on the known functions
of individual galectin regulatory TFs (putative) supported the
role of both Lgals1 and Lgals3 in stem cell proliferation and
differentiation. However, Lgals3 was also implicated/predicted
to play a role in locomotion, response to light, eating
behavior, eye/forebrain/hindbrain development, extracellular
matrix metabolic pathways of collagen and elastin, iron and
calcium homeostasis, regulation of vesicle mediated transport,
Notch/cytokine/JAK-STAT/TGFB2 and smoothened signaling,
viral infection associated processes and acute inflammatory
response (Supplementary Tables S3 and S4).
Lgals8 along with -2,-3,-7, and 9 were putatively regulated
by TF FOXA2 which was associated with the GO term
‘stem cell differentiation’ and ‘regulation of neurogenesis’
(Supplementary Table S5), suggesting the reason for observed
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FIGURE 7 | Comparison and validation of galectins mRNA expression with protein profiling in mouse Hippocampus and Cerebellum. (B,D) ABA based
mRNA expression profile of 3 major galectins in the Dentate Gyrus region of the hippocampus and VII–VIII lobe of the cerebellum is compared with
immunohistochemistry based protein expression in the respective regions as shown in (A,C). DG, dentate gyrus; mo, molecular layer; sg, sub-granular layer (a zone
of adult neurogenesis); po, polymorph layer in DG and Purkinje cell layer in cerebellum; gr, granule cell layer; VII/VIII, 7th and 8th lobe of cerebellum with prepyramidal
fissure(ppf). Pseudo-color calibration bar is included to represent the intensity of expression. Note a good regional corroboration between mRNA and protein
expression except that the protein expression is more widespread due to the secretory nature. The sub-granular zone of the DG that expresses the transcript is
essentially low in intracellular protein pool, probably due to secretion. The protein is also detected in the extracellular space and on surface of cells is suggestive of
autocrine-paracrine effects.
galectin-8, -2,-3, and 9 expression in the hippocampus. Lgals8
was also possibly regulated by glial fate determination gene,
SMARCA4 in the OB and cerebral cortex. SOX2, a neural
stem cell maintenance TF could possibly regulate Lgals8 in
OB, hippocampus and cerebellum, again suggesting a role for
galectin-8 in cell proliferation (Supplementary Table S3). Among
other GO terms of particular interest in the context prediction
of Lgals8 functions were forebrain/hindbrain development,
response to nerve growth factor and establishment/maintenance
of apical-basal cell polarity (Supplementary Tables S5 and
S6). Some of the important brain associated functions such
as response to nutrient and forebrain/eye development were
also predicted for Lgals7 and Lgals4 respectively. Regulation
of lipid kinase activity, lipid storage, PPAR signaling and
response to inflammation and regulation of sister chromatid
cohesion as well as G1/G2 mitotic phase transition processes
were also inferred for Lgals4 (Supplementary Tables S5
and S6). Go classification also suggested that Lgals2 may
have important roles in protein targeting to the nucleus,
stem cell biology and neuronal migration (Supplementary
Tables S5 and S6).
Further, out of 16 TFs putatively regulating Lgals9
(Supplementary Tables S2, S3, and S5), 13 were involved in
‘regulation of developmental process’ (P = 2.39E-10) and
amongst these 13, seven were involved in ‘CNS development’
(P = 3.53E-7) along with some other TFs which had some role in
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FIGURE 8 | Comparison and validation of galectins mRNA expression with protein profiling in mouse Basal ganglia, Ventricular Zone and Substantia
nigra. (B,D,F) ABA based mRNA expression profile of 3 major galectins in the Striatal Caudoputamen (CP, site of activity dependent synaptic plasticity, motor
control and procedural memory) region of the basal ganglia, Ventricular zone: VL (in the vicinity of neurogenic subventricular zone, SVG; and choroid plexus: chpl)
and Substantia nigra (SN, motor control region) is compared with immunohistochemistry based protein expression in the respective regions as shown in (A,C,E).
Pseudo-color calibration bar is included to represent the intensity of expression. Note a good regional corroboration between mRNA and protein expression except
that the protein expression is more widespread due to the secretory nature. The protein is also detected in the extracellular space and on the surface of cells is
suggestive of autocrine-paracrine effects.
making brain development possible. Of specific interest were the
Lgals9 associated GO terms: stem cell proliferation, maintenance
and differentiation; regulation of regeneration, neurogenesis and
gliogenesis; regulation of G1 to S phase cell cycle transition and
asymmetric cell division; response to nutrient, fluid shear stress,
wound healing, oxidative stress and hypoxia; development of
hindbrain, hypothalamus, radial glial and dopaminergic neurons
differentiation; cell-cell adhesion and communication; regulation
of lipid metabolic process; regulation of cholesterol transport
and protein import into the nucleus especially SMAD; positive
regulation of mitochondrial membrane potential and chromatin
remodeling; positive regulation of Notch, Protein kinase B,
canonical WNT and JAK-STAT signaling. One of the most
intriguing GO terms associated with Lgals9 was the ‘response to
the steroid hormone estrogen’, suggesting that this galectin may
be involved in generation of sex specific changes in brain activity
(Supplementary Tables S5 and S6).
In the OB, Lgals9 may have role in memory formation
(EP300), cell cycle regulation (SETDB1) and stem cell
proliferation (POU5F1) based on functions of the putative
regulatory TFs. In cerebral cortex and hippocampus, Lgals9
may be involved in memory formation (EP300), where it
may be additionally involved in stem cell proliferation (MYC,
POU5F1) and differentiation (FOXA2). Lgals9 may also regulate
development of SVZ, hypothalamus and basal ganglia due to
its putative regulation by the forebrain development associated
TF- E2F1. Besides, it may promote neuronal proliferation (MYC,
SETDB1, POU5F1) migration (KLF4) and differentiation of
dopaminergic neurons (FOXA2). In the cerebellum, Lgals9
may be required for glial cell fate (SMARCA4), astrocyte
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differentiation (STAT3) and various aspects of hindbrain
development (SMARCA4) (Supplementary Table S3). So, from
this, it can be said that Lgals9 followed by Lgals8, -1 and -3 may
serve a major role in the mouse brain development, while other
galectins may refine the brain architecture and functions rather
more subtly.
Galectin Family Gene Expression
Analysis in Human
Similar to that in mouse, informatics driven approach identified
a total of 174 TFs in the vicinity of different galectin genes that
could serve as the possible regulators of galectins’ transcription
(Supplementary Table S7). Subsequently, all 174 TFs were taken
together along with the galectins for module detection and
functional network construction. This approach, combined with
literature search on the functions of TFs that putatively regulated
galectins, bestowed us with a unique opportunity to predict the
functions of galectins in the human brain (Supplementary Tables
S9, S16, and S17).
Network Construction and Module
Detection
To identify the unique and biologically important expression
pattern of the transcriptome of galectins in human brain, we
analyzed a high-quality microarray data set from the Allen
Human Brain Atlas (AHBA) using WGCNA (Zhang and
Horvath, 2005; Langfelder and Horvath, 2008) (Supplementary
Tables S10 and S11). This method helped in discovering
the co-expression relationship between genes and enabled
their grouping into modules based on Pearson correlation.
These modules have been used to gain insights into the
functionally related co-expressed genes. This co-expression
weighted network, based on TOM was created by taking the
Pearson Correlation Matrix and transforming it into connection
strength matrix, which is the degree of the shared connection
between the two genes obtained by increasing the correlations
by raising to the threshold power (Yip and Horvath, 2007).
TOM was calculated for each gene pair which considers both
correlation and their shared relationship. In a weighted network,
each gene was assigned to a module and through these tools; we
identified 5 distinct co-expression modules with 16–70 genes per
module as shown in the dendrogram of genes clustered according
to the closeness of the expression pattern (Figure 9A).
Module Membership and Preservation
To represent each module within a network, it was summarized
by module eigengene which is the first principal component
that presents expression profile for that module and helps
in explaining the variability of all genes in a module
(Figure 9B).
Each gene was also provided with another measure called
module membership (kME), which is the absolute value of
correlation between the expression level of each gene in the
network and each module eigengene, along with their P-values
(Supplementary Table S12). This measure informed us about
the level to which a gene belonged to a module on the
scale of 0–1. Genes with high module membership in their
respective modules helped us in elucidating the function of
a member gene based on the annotation of the module. To
know the hub genes of a network, intramodular connectivity
was measured (Supplementary Table S13), which informed us
on how frequently a node interacts with other nodes and genes
with the highest intramodular connectivity were called as the hub
genes. The hub genes helped in identifying module’s functions
or predicting the role of an unknown gene from the module
properties.
Zsummary statistics, a permutation test that creates an
opportunity to test the preservation between different brains
allowed us to assess the preservation of modules in the other
five donor brains with respect to the first donor and the modules
were assigned colors according to the modules from donor brain
1 (B1) for preservation comparisons (Supplementary Tables S14
and S15). Our study showed that genes of the modules with the
same color were highly preserved and stayed together under the
dendrogram (Figure 9A). High preservation score was detected
in 3 out of 5 modules across different donor brains (Figure 9C).
The gene modules (blue, brown, and turquoise) identified in
donor brain 1 were well conserved in other donor brains too,
at the level of regional gene expression, i.e., in structures and
sub-structures, as measured by a module preservation index
(Supplementary Table S15).
Module-Wise Galectin Gene Expression
and Annotation
Genes belonging to a certain module helped in identifying (1)
which all galectins showed similar expression pattern across the
brain; (2) which galectins were enriched in only one part of
the brain and (3) which subregions or major parts of brain
showed similar galectin profiles. Besides this, the variability of
galectin expression could be also analyzed at the global and local
levels with this approach. The variability at the local level could
elucidate more functional roles of genes depending on where
they were expressed, while the variability at the global level could
illuminate us toward the heterogeneity and distinction between
each brain. The relationship of module eigengene expression
profile with individual structures was based on the differential or
relative expression of each galectin and TF across its own absolute
expression.
Out of seven modules indentified, turquoise module
(consisting of LGALS1,-2,-8, and -9) was most preserved across
donor brains. The other modules which showed presence of
galectins were the brown module (LGALS13, -16), blue (LGALS3,
-12) and the green module (LGALS4,-7, -14) (Supplementary
Table S14, please refer to all worksheets).
Out of the five modules that we found in donor brain1
(B1, reference donor), the turquoise module consisted of 70
genes including four galectins (1, 2, 8, 9) (Supplementary Table
S14). This module was positively correlated with globus pallidus
(GP), thalamus (THA), midbrain (MB), cerebellar (CB) nuclei,
Pons (PO) and medulla (MY), while negatively correlated with
cortex (CTX), hippocampus (HP) and the cerebellar cortex
[CB CTX] (Figure 9B). Significant heterogeneity was found in
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FIGURE 9 | Weighted co-expression networks and modules. (A) Top: Dendrogram from gene co-expression network analysis of galectins and their regulators.
Bottom: Modules of co-expressed genes were assigned a color and all modules from each human brain are shown. (B) Module eigengene expressions for different
modules in different brains are shown, FL, frontal lobe; HP, hippocampus; OL, occipital lobe; PL, parietal lobe; AMG, amygdala; STR, striatum; HY, hypothalamus;
THA, thalamus; MB, midbrain; CB, cerebellum; PO, pons; MY, medulla. Selected galectins in each module are shown. (C) Preservation measure Zsummary between
brain 1(B1) vs. the other 5 donor brains.
the hippocampus (HP) for turquoise modules in B1 (brain1)
and B3 (brain 3), where CA4 showed a positive relationship.
Similarly, amygdala (AMY) showed variability in its individual
substructures for this module.
LGALS1 was present in turquoise modules in all the six brains
(Supplementary Table S14) and had a high module membership
value (kME) in all of them, i.e., >0.75 (Supplementary Table
S12). Along with LGALS1, putative TFs which had high kME
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values, showed similar expression patterns in those regions where
the module was positively correlated. With these observations,
it can be said that knowledge on genes in turquoise module for
which some biological process, pathway or function is known,
can assist in validating the established functions as well as
enable the prediction of novel roles for LGALS1 from their close
relationship. A similar approach could be further used for all
other galectins that showed up in the conserved modules.
Apart from the GO terms for the regulation of gene expression
(Supplementary Tables S16 and S17), the turquoise module
was predicted to be enriched in genes involved in ‘immune
system development’ (P = 8.304E-18), ‘cell fate commitment’
(P = 6.851E-13), regulation of cell–cell adhesion (P = 6.051E-
03) and ‘cell proliferation’ (P = 8.856E-13). Among all the
informatics based biological processes identified for turquoise
module, each process showed at least one or more galectins
associated with them, for example, LGALS1 was associated with
GO terms ‘regulation of cell differentiation’ (P = 3.298E-18),
‘cell development’ (P = 3.243E-9), ‘regulation of nervous system
development’ (P = 3.882e-6) and ‘neurogenesis’ (P = 1.595e-
5. TCF12, REST and HDAC1 were the 3 TFs that were
present among the top 10 hubs of turquoise module and were
predicted to be involved in regulation of neurogenesis along
with LGALS1 (Figure 10A, Supplementary Tables S16 and
S17). Similarly, potential functions for other galectins could be
obtained by the logic of guilt-by-association for other modules
too (Figures 10B–F, Supplementary Tables S16 and S17). Apart
from employing GO analysis to predict genes involved in the
process of neurogenesis, we went through the literature and
found 6 more TFs (E2F1, FOXP2, HSF1, IKZF1, SMAD3, and
TAF1) that could be associated with neurogenesis as mentioned
in Supplementary Table S9. For the GO term on the ‘regulation
nervous system development’, 8 out of 11 TFs were putatively
involved in the regulation of LGALS1.
Further, in turquoise module, LGALS8 had over-expression in
hippocampal region and LGALS9 also showed some positivity in
CA4 region. Upon careful consideration of the GO classification
and the positive expression of galectins-8 and 9 in the subregions
of hippocampus, it can be proposed that these two galectins may
be also involved in hippocampal neurogenesis. Interestingly, GO
classifications for putative TFs regulating LGALS8 and LGALS9
also showed that these galectins could be involved in neuronal
survival or neural cell fate determination.
LGALS2 which mainly belonged to turquoise module
according to WGCNA analysis, showed low kME values in all
the brains (<0.5), which suggests that this galectin might not
belong to any particular module or may not have high correlation
with the module eigengene expression, so it needed curation in
each brain individually, by looking at its expression profile and
not by looking at the module eigengene’s expression. Further,
blue (B1) and brown (B1) modules showed positive correlation
with GP and CB cortex. The same modules showed positive
correlation in the DG of HP in atleast 2 brains (B1 and B4),
while in rest of the hippocampal subregions this correlation was
identified to be low (Supplementary Table S12). In the brown
(B1) module, HYP and THA showed variation among all the
subregions (Supplementary Table S12). Similarly, many genes
were expressed in different structures with variable expression
but it was their relative expression level which helped in deciding
if the gene was really expressed in that particular area and
whether the expression was similar across all the regions.
The common predicted theme between blue (B1) and
brown (B1) modules was ‘cell death,’ but the genes in blue
module were also enriched in ‘cell proliferation’ (P = 1.002E-4)
which distinguished this module from brown module even
though they had similar expression pattern for different regions
(Figures 10A,B, Supplementary Tables S16 and S17). Also blue
module (B1) corresponded to GO terms ‘stem cell development’
(P = 2.007E-7), ‘cell cycle’ (P = 5.796E-7), ‘developmental
induction’ (P = 1.251E-4) and like the turquoise module it was
predicted to be involved in ‘cell fate commitment’ (P = 4.163E-
4). In the context of galectins, LGALS3 was the major galectin
present in this module and had putative roles in ‘tissue
development’ (P = 5.77E-5), ‘regulation of cell proliferation’
(P = 2.036E-3) and ‘regulation of cell death’ (P = 7.914E-3).
As we had already searched the literature for more biological
roles in the context of neuronal processes for galectins’ putative
regulatory human TFs (Supplementary Table S9) apart from
those established with the help of GO enrichment analysis,
we could gain further insights into the possible functions of
galectins from the modules with which these TFs were associated.
Through this prediction approach, we found that the turquoise
module showed association with all major brain processes such
as neural cell proliferation, differentiation, neurite extension,
migration, survival and synaptic transmission. The blue, brown,
and green modules showed protection against viruses as a
common function. While the activation of neural gene process
was uniquely associated with turquoise module; neural stem
cell differentiation and lateral ventricle differentiation were
exclusively associated with blue and brown modules respectively.
Both green and the brown modules were also more associated
with processes pertaining to differentiated neurons such as
synaptic plasticity, synaptic transmission and other synaptic
functions (Supplementary Tables S18–S21).
The other possible roles played by the members of blue
module (LGALS3, -12) included neural migration, neuronal
survival/anti-apoptosis, CNS development and neural
differentiation (Figure 10C, Supplementary Tables S16 and S17).
The green module (LGALS4, -7, -14) was not preserved
with high confidence in all the brains (Supplementary Table
S15), but LGALS4 and LGALS14 were well maintained in
most of them (Figure 9B, Supplementary Table S14) and were
amongst the hubs in green module network of some of the
brains (Supplementary Tables S12 and S13, Figure 10B). Hence,
functions associated with the members of green module could
highlight some viable role for both LGALS4 and LGALS14. In
the donor brain 6 (B6), LGALS9 had high membership in green
module of some donor brains (Figure 9B, Supplementary Table
S14) which again demonstrates the heterogeneity between donor
brains and that the age, diet, ethnicity, gender etc. could majorly
regulate galectins’ expression (Rhodes et al., 2013).
Another important observation that we made was that
even though the total number of genes belonging to a
module differed in each brain (Supplementary Table S14),
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FIGURE 10 | Network plots showing co-expression interaction of module for which module eigengene expression is shown in Figure 9B. (A) Brain 1
(B1) turquoise module, (B) Brain 1 brown module, (C) Brain 1 blue module, (D) Brain 2 green module, (E) Brain 6 green module, (F) Brain 6 brown module. Color of
each node represents measure of intramodular connectivity; node size denotes the between-ness centrality and color of edges show the edge between-ness, which
is the weight of each edge. Major GO classification terms are mentioned against each module. Conserved galectins in each module are also indicated.
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some of the intramodular hub genes (mainly top 5 in each
module) were remarkably reproducible across the human brains
(Supplementary Tables S12 and S13). For example, RE-1 silencing
transcription factor (REST) was consistently identified as hub
in Brains 1, 2, 3, and 5 in the turquoise module and this
TF has been shown to have a role in neurogenesis (Gao
et al., 2011) and neuronal differentiation (Su et al., 2004).
Similarly, EZH2, associated with functions in neural migration,
proliferation and neurogenesis and SETDB1 which is connected
with roles in neuronal survival and CNS development were
identified to be hubs in brains 1, 2, 3 and 4 in the blue module
(Supplementary Tables S12, S16, and S17). This information
highlights that in general, the important brain functions and
processes were preserved as hubs in all the donor brains,
resurrecting the fact that human brain are fundamentally similar
and the divergences in gene expression profiles were rather more
subtle.
Emergent knowledge on the ‘preservation of hub genes’
presented one more advantage to this analysis which surprisingly
revealed that the TFs that emerged as hubs were also the
putative regulators of galectins in each module (Figure 10,
Supplementary S14). For example, out of 10 TF hubs in
turquoise module, 7 hubs regulated LGALS1, 9 hubs regulated
LGALS2, 8 hubs regulated LGALS8 and 9 hubs regulated
LGALS9. Similarly in the blue module, 9 hubs regulated LGALS3
and in the brown module 7 hubs regulated LGALS13. This
analysis thus helped us in deciphering the deeper insights
into the overall uniqueness of brain spatial transcriptomics
heterogeneities as well as commonalities from the results
obtained on spatial organization of galectins and their predicted
regulators.
Comparative Gene Expression Analysis
between Mouse and Human
Upon comparing the data driven expression of galectins in
mouse and humans at a global level, Lgals9 showed both the
widespread and the highest expression in all the brain regions in
mouse, while in humans, LGALS1 had almost absolute ubiquitous
expression, but relative to individual structures, it was under-
expressed (Supplementary Table S22). At a local level, that is at
the scale of individual structures and substructures some regions
showed similar profiles of galectins and other structures showed
an opposite trend. This was much anticipated as mouse is an
evolutionary different species and has predominantly different
physiology than human. Species specific spatial distribution
of molecular signatures between mouse and human brain
has been previously reported (Zeng et al., 2012) and this
fact could be the major cause of the observed differences in
regional identity, the levels and distribution of galectins in these
species.
Strikingly, in the human hippocampus, considering only
the absolute expression values, DG region showed the highest
expression of LGALS1 amongst all galectins but overall the
expression of LGALS8 was the highest (Supplementary Table
S22). On contrary, in mouse hippocampus, Lgals9 showed the
highest expression in DG whereas its expression was the third
lowest in human in the same region (Supplementary Table S4,
Figures 3A and 4A).
In humans, the galectins’ expression in amygdala was divided
into substructures, where individual structure has expression
close to its mean, LGALS1 showed the highest absolute expression
closely followed by LGALS8 while LGALS9 and LGALS12 were
the lowest (Supplementary Table S22). However, in mouse
amygdala, Lgals9 expression was the highest followed by Lgals8,
which points to the consistency of expression of galectin-8
which was highly preserved in both the species (Supplementary
Table S4, Figures 3E and 5A). Similarly, LGALS3 showed high
expression in human amygdala but it was low for mouse.
However, some conservation in galectin-3 expression profile was
observed for hypothalamus and thalamus in both the species.
In human basal ganglia, consisting of globus pallidus
(GP) and striatum (Str), galectins -1, 3, and 8 showed high
expression, on contrary, in mouse, the expression of these
galectins was the lowest in the same region (Supplementary
Table S4, Figures 2C and 5A). While Lgals9 showed highest
expression in mouse, it showed an opposite trend in human,
where its expression was amongst the lowest. So, basal ganglia
also served as a case where the profile between mouse
and human was quite opposite (Supplementary Table S4;
Figure 5A). However, it is to be noted that the contribution
of galectin-9 to brain structure and functions cannot be
underestimated in humans as it has been documented to control
significant cellular and pathological signaling (John and Mishra,
2016).
One of the important brain structures which develops mostly
postnatally in mouse and in utero in human is the cerebellum
(Haldipur et al., 2012). In this part of the human brain, LGALS2
was least expressed (Supplementary Table S22), which was quite
consistent with its expression in mouse (Supplementary Table
S4; Figure 5A). But the other galectins did not follow the
same trend. In the mouse cerebella, Lgals9 had the highest
expression across galectins, while in humans it was quite low as
compared to the other galectins (Supplementary Tables S4 and
S22, Figure 5A).
Although for mouse, the expression analysis for cortex was
done layer-wise and in humans it was according to the lobes
and its different sub-structures, it was observed that in mouse,
Lgals9 had the highest average expression across the layers among
all the galectins analyzed, while in humans too, this galectin
had maintained the same kind of profile for the cortex, hence
the two different techniques employed to identify galectin-TF
transcript expression (ISH for mouse vs. microarray for human)
well corroborated with each other.
Substantia nigra, consisting of dopaminergic neurons showed
high density and moderate expression of Lgals9 in mouse
(Supplementary Table S4; Figure 5A), but in human, the
expression was low as compared to galectins 1, 3 and 8, where
LGALS1 was the highest (Supplementary Table S22: please see all
worksheets).
Between mouse and human, 18 common TFs were predicted
to be involved in regulating the expression of different galectins
(Supplementary Table S8). Amongst those, 4 did not pass the
image quality test by ABA and hence the remaining 14 were
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analyzed by using the ISH images in mouse. Among these 14
common TFs, SMARCA4 and SOX2 showed the highest absolute
expression values in human across all the regions (Supplementary
Table S22: please see all worksheets). In mouse, these two TFs
came together along with Lgals8 when clustered hierarchically
(Supplementary Table S4; Figure 5B), hence pointing to the co-
expression of these TFs with Lgals8 in both the species. The major
role for these TFs has been reported in neurogenesis, which again
validated their co-expression probably for the co-ordination of
a common function. But in humans, only SMARCA4 putatively
regulated galectin-8 depicting a difference in the regulation in
different species.
EZH2 which is involved in neurogenesis, neuronal migration
and memory formation, in both humans and mouse, had very
low expression in mouse hippocampus (Supplementary Table S4;
Figure 5B) but had few cells with low level average expression in
the SGZ of DG in mouse. Similarly, human brains showed highest
absolute expression of this TF among all sub-regions of the
hippocampus (Supplementary Table S22). This TF also putatively
regulated galectins-8 and 9 in both the species (Supplementary
Tables S4 and S22, Figure 5B: please see all worksheets).
E2F1 has been reported for a role in neural development
and neuronal survival and our analysis showed that it regulated
all the galectins (1, 2, 3, 4, 7, 8, and 9) in mouse, with the
highest expression among all the galectins and putative regulatory
TFs. On contrary, its expression was among the lowest in
humans, although it theoretically regulated the same galectins
there too except for galectin-7 (Supplementary Tables S4 and S22,
Figure 5B: please see all worksheets). This differences in levels
of expression in both species suggest that either there may
be different complex of TFs that were involved with this TF
for its regulatory function or that the low levels of expression
in human was sufficient for the proper regulation of its
target genes. Similarly, there were several more TFs that were
predicted to be common between the two species, which may
have different regulatory roles and expression (Supplementary
Table S8).
DISCUSSION AND CONCLUSION
The major goals of the study were to describe (1) the
neuroanatomical organization of galectins in brain substructures
of mouse and human species [data driven] (2) predict probable
functions of galectins through the known functions of co-
expressed galectins’ putative regulatory TFs [informatics driven]
and (3) to compare both intra and inter-species specific
differences as well as the extent of conservation in galectins’
expression across brain structures and sub-structures [data and
informatics driven inferences].
Here, to the best of our knowledge, it is for the first time that
the brain-centered gene expression profile of galectins has been
systematically described via the biocuration of raw ISH images of
adult mouse from the ABA and the normalized microarray data
for six human donor brains from the AHBA. Further, through a
novel strategy of extrapolation of the regulatory TFs functions,
galectins probable roles in the generation of brain heterogeneity
are deduced and functional networks are generated, which now
lays a strong ground for further detailed experiments.
Allen Brain Atlas driven neuro-anatomical/neuroinformatics
studies have been particularly successful in accelerating the
understanding of brain across species and has been vital in
many innovations related to brain drug therapeutics5 (Allen
Brain Atlas: 5 years and Beyond; Jones et al., 2009; Sunkin
et al., 2013). Since the semi-quantitative approach for gene
expression has been followed for all genes with ‘one size fits
all’ high throughput approach, ABA, in recent years, has been
robustly curated for further ‘context dependent analysis’ by
independent investigators (Jones et al., 2009). However, the
ABA has clearly discussed the technical reproducibility of
ISH data over several sections from the same mouse brain6
(follow ‘Documentation’ Tab- In Situ Hybridization and
Supplemental Data-ISH Platform Validation). They have also
run appropriate positive and negative controls for the ISH data6
(follow ‘Documentation’ Tab-Supplemental Data-ISH Platform
Controls). The data is generated on inbred mouse strain and
excellent reproducibility across group of animals has been
verified by re-examining the ISH patterns of about 1000 genes
from the big dataset6 (follow ‘Documentation’ Tab-Supplemental
Data-Comparison of the Top 1000 Genes) that confirms the
ABA is a highly reliable, non-profit resource to neuroscientists
for proposing challenging hypothesis for innovative and
frontier research in brain sciences. Further, Allen Brain Atlas
data has been verified to be highly accurate and consistent
with the peer-reviewed literature and other independent high
throughput brain gene expression/radioactivity based ISH
databases such as BGEM and those generated by Prof. Fred
Gage team (Lein et al., 2004, 2007)6 [follow ‘Documentation’
Tab-Supplemental Data-Cross Platform Validation]. The
reproducibility and reliability of data is thoroughly discussed
and demonstrated in supplementary section of the following
publication: http://www.nature.com/nature/journal/v445/n7124/
suppinfo/nature05453.html; http://www.nature.com/nature/jour
nal/v445/n7124/pdf/nature05453.pdf) and is also demonstrated
by others5 (Allen Brain Atlas: 5 years and Beyond; Jones et al.,
2009). Our own work is similar to previous report that biocurated
the ABA ISH data and found good concordance with the protein
expression (Zhang et al., 2008). Furthermore, the normal human
brain gene expression microarray data is available at the ABHA
platform for minimum six donors for a reliable intra and
interspecies cross comparisons, besides, the comparisons within
the brain regions of each donor is made possible. Hence, we
resorted to ABA and ABHA as a reliable platform to begin
systematizing the ‘science of galectins’ in the perspective of brain
structural organization and regulation.
Galectins have been deeply studied and elucidated in the
functioning of immune system and with the discovery of
immune system in brain (Louveau et al., 2015), it becomes all
the more necessary and timely to understand the expression
and roles of galectins in CNS. For example, immune system
5http://www.alleninstitute.org/what-we-do/brain-science/research/scientific-pub
lications/
6http://mouse.brain-map.org/
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molecule IFNγ that has been recently shown to be involved
in generating neuronal connectivities is crucially regulated by
galectins (Blouin et al., 2016; Filiano et al., 2016; John and
Mishra, 2016). Gal-3 aberrations have been identified to be hub
in autism associated disorders, again pointing to the role in brain
wiring and generation of social behavior (Voineagu et al., 2011).
Besides, given the secretory nature of galectins, the detailed CNS
expression, and regional enrichment and spread as morphogens
needs to be timely elucidated to understand the role of this family
of proteins in regulation of CNS architecture and functional
circuits for cognitive performance and behaviors.
Our analysis revealed many intricacies in the expression
profiles of galectins and their regulatory TFs in different regions
of brain which has led us to uncover (1) informatics driven
potential functions for individual galectins in brain, (2) reflect on
the species specific signatures and (3) brain mRNA transcriptome
regional and cellular heterogeneities via curation of ABA data.
This approach to understand galectins’ regional expression
and functions via their regulatory TFs was particularly useful
because the ‘cellular identity and function’ for defining the
phenotype and genotype of diverse cells from multiple different
regions has been observed to be the end product of the
precise regulation of gene expression in each cell type. This
control of gene expression is maintained by cell- or tissue-
specific TFs (Müller et al., 1988; Vaquerizas et al., 2009) and
their misregulation can lead to a variety of brain defects
and neurodegenerative disorders such as Parkinson’s disease,
Alzheimer’s disease and Amylotrophic Lateral Sclerosis (ALS)
(Miller et al., 2006; Cooper-Knock et al., 2012; Ziats et al., 2015).
In fact, the regional heterogeneity in expression of galectin
transcripts in brain could be a net outcome of distinct cellular
transcriptional complex which consists of multiple TFs that
outline the identity and function of cells in a region by
regulating differential gene expression. This transcriptional
complex consists of (1) facilitators which are ‘expressed in all the
cells of a region’ and regulate multitude of genes and (2) specifiers
which ‘distinguishes these cells into different cell types’ to give a
context to these cells by regulating only specific genes (Vaquerizas
et al., 2009). Our analysis in mouse revealed that four TFs, CTCF,
E2F1, ESRRB and KLF4 could act as facilitators in the regulation
of galectins as they were found to be putatively regulating all of
them amidst the specifiers.
Further, the regional heterogeneity of the transcript is a
direct function of the availability of transcription binding sites
(TFBS) in the cell type. Chromatin immunoprecipitation with
sequencing (ChIP-seq) (Johnson et al., 2007) has paved the way
for identifying transcription factor binding sites (TFBS) in target
genes that helps in elucidating the regulatory networks of a gene
and even a whole family of genes. The putative TFBS obtained
for galectins were located both far and near to their promoter sites
and many of these sites are the possible locations where enhancers
may bind and regulate galectins expression.
In ABA data curation, we find that several galectins were
expressed in the same brain regions at the same time, though in a
non-overlapping pattern in some neuronal populations and also
with differing intensities. Hence, the differences in the regional
expression of galectins and their predicted regulators in different
brain structures may be explained to be occurring as follows:
First, there could be a differential binding of TFs at the promoter
sites. Second, there could be differences in cell density, in cell
type, their morphology and the circuits they form with the
other cell types in the same structure or in the different parts
of the brain. Third, there could be differences in the activity
of the cell type studied in different regions, that is, whether
it is excitatory or inhibitory. Fourth, this could be due to the
differences in the positioning of the brain regions (lateral, para-
sagittal or mid-sagittal, for example). Finally, each cell in a region
could be regulated separately or there could be differences in the
regulation of different cell types in a region (Kasukawa et al.,
2011) as was the case for Lgals1 in the L5 of cortex, where
only few cells expressed this galectin but strongly. Therefore,
this diversity and distribution of different cell types in different
structures of adult brain may underpin the regional complexity
in its transcriptome too.
There could also be other extrinsic and intrinsic factors
that could govern galectins’ expression heterogeneity and
preservation. For instance, we identified a set of local neural
circuits where the same galectin is expressed across the circuit and
establishes the positive function of those circuits. For example
in mouse brain, Lgals3 and Lgals8 were positively expressed
in the cerebellar PCL and these cells provided output from
the cerebellar cortex to the DCN, which too were positive for
both of them. The heterogeneity of galectins in the Ammon’s
horn of the hippocampus was possible due to the differences
in the morphology of cells in each CA region. Similarly, the
unique expression pattern was obtained for cerebellum in all
human brain modules, which was quite distinctive in its module
eigengene expression from the rest of the brain (Lein et al., 2007;
Kang et al., 2011; Liscovitch and Chechik, 2013) probably to due
to its development taking place after the birth (to some extent),
unlike the rest of the brain development.
Contrary to data driven expression analysis, the prediction
of functions for galectins was majorly possible by studying the
co-expression of galectins and putative regulatory TFs between
different regions and co-relating this information with the
cellular identities of those regions. In human micoarray-based
transcriptome analysis, the enrichment of genes in specific
modules could also reveal unique gene signatures and functions
for the un-annotated genes. Similarly, identification of different
modules with different numbers of co-expressed genes, enabled
prediction of the function of galectins in those modules with the
aid of already known functions of the other members of that
module by the principle of ‘guilt by association’ (Oldham et al.,
2008). This possibility of shared function for the genes involved
in each module based on the co-expression analysis from the
microarray data has been described in earlier studies too (Hughes
et al., 2000; Segal et al., 2003). In ABA data, we have indeed seen
that for the co-expressed genes, expression profile of TFs at least
matches partly with that of its targets, as was the case for Lgals9
and Lgals8 in mouse cortex.
Another point that must be highlighted here is that the
number of possible TFs regulating galectins in humans ranged
from 72 for LGALS7 to 152 for LGALS9. There were large number
of TFs that were common across all galectins. It is only by treating
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each galectin with its own regulators in WGCNA analysis,
that we could generate modules where many of the regulators
were separated on the basis of co-expression. A combination of
galectins and their putative regulatory TFs’ transcript expression
hence unveiled the prospective functions of galectins, because
genes that cluster together are observed to share similar roles.
Similar to mouse brain, both measures of preservation and
heterogeneity were observed for human brains, where the
general framework for the brain development comprising of
anatomically similar structures and resident neural circuitry
established preservation. On the other hand, heterogeneity was
possible due to differences in expression pattern, differences
in the number of structures studied for each brain, age, sex,
ethnicity and even diet of the brain donors. Preservation helped
in identifying the common functions of genes in all donor brains
while heterogeneity revealed another possibility of identifying a
distinct role in different brains.
Hence, by systematically analyzing the gene expression in
both mouse and human and comparing it in the common
structures from both the organisms, we were provided with an
opportunity to cautiously but promisingly consider mouse as
a model organism for galectin associated brain diseases based
on their transcriptome profiling in the two species which is
akin to studies that have already established the conservation
of gene expression between mouse and human (Strand et al.,
2007).
Gene ontology analysis of different modules in human brains
and possible regulators of galectins analyzed individually in
both mouse and human, predicted enrichment in neurogenesis,
neural cell migration, gliogenesis, response to wound healing,
CNS development, cell fate commitment, cell proliferation,
cell differentiation, cell cycle and regulation of cell death.
With further identification of functions for different TFs
in brain through literature search, we could predict more
functions for galectins such as synaptic plasticity and maturation,
neuronal survival, neural differentiation, neurite extension,
protection against viral infection, response to inflammation
etc., (Supplementary Tables S18–S21). Therefore, the method
of analysis presented here display several opportunities. This
method enabled (1) prediction of novel functions for galectins
that has generated ‘leads for further experimental work,
(2) it highlighted common and species specific galectin
expression regulatory networks and (3) it identified brain
microstructured-fine tuned heterogeneity and as the GO
data is progressively updated, it can enable further more
predictions of galectin functions in brain. Overall, this study
sufficiently highlights that galectins heterogeneous transcriptome
diversifies molecular and functional anatomy in both mouse
and human brain. Hence, in conclusion, galectins can be
considered as novel and emerging molecular signatures of
brain heterogeneity. Ongoing studies in our lab on galectin-
TFs structure-function relationship in mammalian brain will
lend insights into the patho-physiological relevance of galectins
expression and regulation and may further enable efficient
maneuvering of these molecules for both therapeutics and
regenerative purposes. Our recently acquired data makes it
clear that the expression mask generated by our methodology
corroborates well with galectin protein expression profile vs.
the expression mask available at the Allen Brain Atlas ( please
see Figures 6–8; Supplementary Figure S15, detailed study
on galectins developmental-adult protein expression will be
communicated soon).
Overall, the major highlights of this work suggest that (i)
galectins have a highly heterogeneous transcript expression
within and across mouse and human brain anatomical locations
(ii) galectins are predicted crucial targets of brain enriched
TFs (iii) galectin-1, -3, -8, and -9 may regulate several
neuronal processes, while galectins-2,4,6,7 and 12 may regulate
more specialized and localized functions (iv) galectins-8 is
most conserved across mouse and human brain (v) and
finally, due to diverse regional distribution within and across
species, galectins-the well known family of immune system
proteins may be considered as novel signatures of brain
heterogeneity and functions with several similarities to other
recently reported HLA family of immune system proteins
in the mammalian brain (Boulanger, 2009; Darmanis et al.,
2015).
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